HSCT Graft vs Host Disease (GVHD)

There is a knowledge deficit in the pathophysiology, morbidity, mortality, and treatment options associated with GVHD. Gaps in knowledge can lead to slower recognition, treatment, and advocacy for this patient population. Since immunosuppression is currently the mainstay of treatment these patients are at increased risk for infection and other secondary complications from acute and chronic GVH. 

Release Date:
October 2021

Expiration Date:
October 2024

Estimated Duration of Course:
1 hour

This offering carries 1.00 ANCC nursing contact hour.

Target Audience

The target audience is RNs, APPs, and those providing direct clinical care to this patient population. 

Learning Objectives

  • Describe the pathophysiology and diagnosis of patients with acute and chronic GVH. 
  • List the treatment options related to the care of a patient experiencing GVHD. 

Additional Information

Provided by: 

The Norman Knight Nursing Center     

Please visit our website at mghpcs.org/KnightCenter   

Course version: 6.2021

Course summary
Course opens: 
10/01/2021
Course expires: 
10/31/2024
Cost:
$0.00
Rating: 
0

Presenter

Zachariah DeFilipp, MD 

Nurse Planner

Patricia Crispi PhD(c), RN, NPD-BC 

Content Expert

Giuliana De Marchi, NP 

Planning Committee

Maria Alfonso, RN 

Colleen Walsh, RN 

Accreditation:

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Price

Cost:
$0.00
Please login or register to take this course.